DocGo (DCGO) Stock Price

DocGo Price

NASDAQ·CLOSED
0.63USD-0.0023 (-0.37 %)
Market closed

Over the last 4 years DocGo grew revenue by 60.0% annually, reaching 616.56 M USD. Earnings per share have declined at 9.9% per year over the last 3 years. For DocGo, the net margin of 3.2% is up versus -15.3% a few years ago. The consensus 12-month price target for DocGo is 3.06 USD, about 389.6% above where the stock trades today. Of 12 analysts, 8 rate the stock a buy — an overall Buy consensus. The stock trades about 36% above its 52-week low.

DocGo stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of DocGo over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how DocGo stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing DocGo's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

DocGo Stock Price History
DateDocGo Price
8/6/20260.63 USD
8/5/20260.63 USD
8/4/20260.65 USD
8/3/20260.65 USD
7/31/20260.65 USD
7/30/20260.67 USD
7/29/20260.68 USD
7/27/20260.60 USD
7/23/20260.67 USD
7/22/20260.67 USD
7/21/20260.64 USD
7/20/20260.67 USD
7/17/20260.65 USD
7/16/20260.64 USD
7/15/20260.67 USD
7/14/20260.64 USD
7/13/20260.64 USD
7/10/20260.60 USD
7/9/20260.60 USD
7/8/20260.54 USD
7/7/20260.60 USD
7/6/20260.56 USD
7/2/20260.56 USD
7/1/20260.55 USD
6/30/20260.52 USD
6/29/20260.52 USD
6/26/20260.49 USD
6/25/20260.46 USD
6/24/20260.50 USD
6/23/20260.51 USD
6/22/20260.53 USD
6/18/20260.52 USD
6/17/20260.57 USD
6/16/20260.58 USD
6/15/20260.58 USD
6/12/20260.58 USD
6/11/20260.57 USD
6/10/20260.56 USD
6/9/20260.58 USD
6/8/20260.55 USD
6/5/20260.56 USD
6/4/20260.57 USD
6/3/20260.57 USD
6/2/20260.63 USD
6/1/20260.63 USD
5/29/20260.66 USD
5/28/20260.66 USD
5/27/20260.63 USD
5/26/20260.63 USD
5/22/20260.63 USD
5/21/20260.60 USD
5/20/20260.61 USD
5/19/20260.57 USD
5/18/20260.55 USD
5/15/20260.57 USD
5/14/20260.60 USD
5/13/20260.59 USD
5/12/20260.60 USD
5/11/20260.59 USD
5/8/20260.57 USD
5/7/20260.63 USD
5/6/20260.62 USD
5/5/20260.68 USD
5/4/20260.68 USD
5/1/20260.67 USD
4/30/20260.71 USD
4/29/20260.71 USD
4/28/20260.72 USD
4/27/20260.69 USD
4/24/20260.72 USD
4/23/20260.68 USD
4/22/20260.74 USD
4/21/20260.69 USD
4/20/20260.68 USD
4/17/20260.65 USD
4/16/20260.58 USD
4/15/20260.53 USD
4/14/20260.54 USD
4/13/20260.58 USD
4/10/20260.52 USD
4/9/20260.58 USD
4/8/20260.55 USD
4/7/20260.57 USD
4/6/20260.57 USD
4/2/20260.57 USD
4/1/20260.57 USD
3/31/20260.63 USD
3/30/20260.60 USD
3/27/20260.58 USD
3/26/20260.60 USD
3/25/20260.61 USD
3/24/20260.64 USD
3/23/20260.67 USD
3/20/20260.67 USD
3/19/20260.66 USD
3/18/20260.69 USD
3/17/20260.78 USD
3/16/20260.65 USD
3/13/20260.66 USD
3/12/20260.62 USD
3/11/20260.65 USD
3/10/20260.64 USD
3/9/20260.67 USD
3/6/20260.67 USD
3/5/20260.70 USD
3/4/20260.73 USD
3/3/20260.70 USD
3/2/20260.69 USD
2/27/20260.72 USD
2/26/20260.71 USD
2/25/20260.72 USD
2/24/20260.74 USD
2/23/20260.74 USD
2/20/20260.79 USD
2/19/20260.81 USD
2/18/20260.81 USD
2/17/20260.80 USD
2/13/20260.75 USD
2/12/20260.71 USD
2/11/20260.73 USD
2/10/20260.76 USD
2/9/20260.73 USD
2/6/20260.78 USD
2/5/20260.70 USD
2/4/20260.68 USD
2/3/20260.72 USD
2/2/20260.78 USD
1/30/20260.77 USD
1/29/20260.81 USD
1/28/20260.82 USD
1/27/20260.87 USD
1/26/20260.80 USD
1/23/20260.84 USD
1/22/20260.85 USD
1/21/20260.85 USD
1/20/20260.81 USD
1/16/20260.83 USD
1/15/20260.90 USD
1/14/20260.89 USD
1/13/20260.87 USD
1/12/20260.90 USD
1/9/20260.89 USD
1/8/20260.91 USD
1/7/20260.91 USD
1/6/20260.94 USD
1/5/20260.89 USD
1/2/20260.89 USD
12/31/20250.88 USD
12/30/20250.88 USD
12/29/20250.89 USD
12/26/20250.93 USD
12/24/20250.92 USD
12/23/20250.88 USD
12/22/20250.88 USD
12/19/20250.89 USD
12/18/20250.94 USD
12/17/20250.94 USD
12/16/20250.91 USD
12/15/20250.92 USD
12/12/20250.92 USD
12/11/20250.94 USD
12/10/20250.98 USD
12/9/20251.00 USD
12/8/20251.01 USD
12/5/20251.05 USD
12/4/20251.05 USD
12/3/20251.08 USD
12/2/20250.96 USD
12/1/20250.97 USD
11/28/20251.03 USD
11/26/20251.04 USD
11/25/20251.02 USD
11/24/20251.02 USD
11/21/20250.97 USD
11/20/20250.88 USD
11/19/20250.92 USD
11/18/20250.93 USD
11/17/20250.96 USD
11/14/20251.07 USD
11/13/20251.04 USD
11/12/20251.09 USD
11/11/20251.10 USD
11/10/20251.11 USD
11/7/20251.11 USD
11/6/20251.07 USD
11/5/20251.08 USD
11/4/20251.02 USD
11/3/20251.03 USD
10/31/20251.09 USD
10/30/20251.05 USD
10/29/20251.08 USD
10/28/20251.14 USD
10/27/20251.14 USD
10/24/20251.18 USD
10/23/20251.26 USD
10/22/20251.27 USD
10/21/20251.49 USD
10/20/20251.20 USD
10/17/20251.16 USD
10/16/20251.22 USD
10/15/20251.25 USD
10/14/20251.30 USD
10/13/20251.27 USD
10/10/20251.15 USD
10/9/20251.20 USD
10/8/20251.26 USD
10/7/20251.27 USD
10/6/20251.24 USD
10/3/20251.27 USD
10/2/20251.28 USD
10/1/20251.31 USD
9/30/20251.36 USD
9/29/20251.38 USD
9/26/20251.37 USD
9/25/20251.39 USD
9/24/20251.46 USD
9/23/20251.48 USD
9/22/20251.48 USD
9/19/20251.45 USD
9/18/20251.55 USD
9/17/20251.48 USD
9/16/20251.53 USD
9/15/20251.56 USD
9/12/20251.53 USD
9/11/20251.57 USD
9/10/20251.51 USD
9/9/20251.58 USD
9/8/20251.57 USD
9/5/20251.58 USD
9/4/20251.51 USD
9/3/20251.55 USD
9/2/20251.54 USD
8/29/20251.56 USD
8/28/20251.63 USD
8/27/20251.62 USD
8/26/20251.65 USD
8/25/20251.64 USD
8/22/20251.72 USD
8/21/20251.60 USD
8/20/20251.61 USD
8/19/20251.59 USD
8/18/20251.68 USD
8/15/20251.62 USD
8/14/20251.63 USD
8/13/20251.73 USD
8/12/20251.66 USD
8/11/20251.53 USD
8/8/20251.57 USD
Access this data via the Eulerpool API

DocGo Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
94.10 M USD
-11.10 M USD
-14.40 M USD
Jan 1, 2021
318.70 M USD
19.30 M USD
23.70 M USD
Jan 1, 2022
440.50 M USD
32.10 M USD
34.60 M USD
Jan 1, 2023
624.29 M USD
15.32 M USD
6.86 M USD
Jan 1, 2024
616.56 M USD
28.69 M USD
19.99 M USD
Jan 1, 2025 (e)
323.98 M USD
-92.86 M USD
-53.87 M USD
Jan 1, 2026 (e)
297.18 M USD
-47.34 M USD
-34.32 M USD
Jan 1, 2027 (e)
324.94 M USD
-34.64 M USD
-22.28 M USD

DocGo Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 8, 2026, 10:56 AM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
202020212022202320242025e2026e2027e
94.00318.00440.00624.00616.00323.00297.00324.00
238.3038.3641.82-1.28-47.56-8.059.09
32.9834.2835.0031.2534.5834.5834.5834.58
31.00109.00154.00195.00213.00111.69102.70112.03
-11.0019.0032.0015.0028.00-92.00-47.00-34.00
-11.705.977.272.404.55-28.48-15.82-10.49
-14.0023.0034.006.0019.00-53.00-34.00-22.00
-264.2947.83-82.35216.67-378.95-35.85-35.29
58.4094.90103.00105.62109.42109.42109.42109.42
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales DocGo generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue DocGo retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare DocGo's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares DocGo has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against DocGo's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

DocGo stock margins

The DocGo margin analysis displays the gross margin, EBIT margin, as well as the profit margin of DocGo. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for DocGo.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
33.26 %
-11.80 %
-15.30 %
Jan 1, 2021
34.42 %
6.06 %
7.44 %
Jan 1, 2022
35.12 %
7.29 %
7.85 %
Jan 1, 2023
31.30 %
2.45 %
1.10 %
Jan 1, 2024
34.64 %
4.65 %
3.24 %
Jan 1, 2025 (e)
34.64 %
-28.66 %
-16.63 %
Jan 1, 2026 (e)
34.64 %
-15.93 %
-11.55 %
Jan 1, 2027 (e)
34.64 %
-10.66 %
-6.86 %

DocGo Stock Revenue, EBIT, Earnings per Share

The DocGo earnings per share therefore indicates how much revenue DocGo has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
1.61 USD
-0.19 USD
-0.25 USD
Jan 1, 2021
3.36 USD
0.20 USD
0.25 USD
Jan 1, 2022
4.28 USD
0.31 USD
0.34 USD
Jan 1, 2023
5.91 USD
0.15 USD
0.06 USD
Jan 1, 2024
5.63 USD
0.26 USD
0.18 USD
Jan 1, 2025 (e)
3.31 USD
-0.85 USD
-0.55 USD
Jan 1, 2026 (e)
3.04 USD
-0.43 USD
-0.35 USD
Jan 1, 2027 (e)
3.32 USD
-0.32 USD
-0.23 USD

DocGo business model & stock analysis

The history of DocGo Inc began in 2014 when the idea was born to develop a mobile app for doctor appointment scheduling and health monitoring. The founders recognized a rising demand for faster and more convenient access to medical services. From this vision, DocGo Inc was created. DocGo Inc's business model includes a range of mobile applications that improve access to medical care. The main application is DocGo, which allows users to book doctor appointments and track and manage their health data. This app also offers a feature for monitoring chronic conditions such as diabetes or high blood pressure and automatically sends reports on the status of these conditions to the user's doctor. Another important product from DocGo is the telemedicine system, which allows users to receive early assessments and diagnoses from doctors through video and chat. This helps avoid many cases where patients need to physically visit a doctor, saving time and money. DocGo has also developed a mobile pharmacy app that allows patients to order their medications directly through the app and have them delivered to their homes. This app also has interactive features such as a reminder function that notifies the user when to take their medications. Another important aspect of DocGo is its integration with wearables, which allows users to measure and send their health data to the app in real time. DocGo also utilizes artificial intelligence and machine learning to identify health risks in users and provide recommendations for medications and treatments. In recent years, DocGo has expanded in various areas. The company has formed partnerships with major healthcare organizations and hospitals to create a broader network of care. DocGo has also developed an API that allows other companies to integrate their health data into the DocGo system. Overall, DocGo has made a significant contribution to improving access to medical care, particularly during the COVID-19 pandemic. By providing telemedicine and mobile pharmacy services, as well as managing health data, DocGo has helped democratize and enhance healthcare.

DocGo SWOT Analysis

Strengths

DocGo Inc is backed by a highly experienced and competent team of medical professionals, software engineers, and business experts. This diverse expertise enables the company to develop innovative and effective solutions for the healthcare industry.

The company's flagship product, DocGo App, provides a user-friendly interface that allows patients to easily manage their medical records, schedule appointments, and communicate with healthcare providers. This convenience enhances patient satisfaction and engagement.

DocGo Inc has established strong partnerships with leading healthcare institutions and medical professionals. These partnerships help the company to expand its reach, improve product quality, and gain a competitive edge in the market.

Weaknesses

Being a relatively new entrant in the market, DocGo Inc faces challenges in terms of brand recognition and establishing trust among potential users. This could lead to slower adoption rates and difficulty in attracting a large user base initially.

The company's reliance on technology and digital platforms for its services may pose a barrier to adoption for individuals who are less tech-savvy or have limited access to digital devices and internet connectivity.

Opportunities

The increasing adoption of telemedicine and remote healthcare services presents a significant opportunity for DocGo Inc. The company's platform can facilitate virtual consultations, remote monitoring, and electronic prescriptions, addressing the growing demand for convenient and efficient healthcare solutions.

DocGo Inc can explore collaborations with insurance providers to integrate their platform with insurance networks. This would enable seamless claims processing, streamlined healthcare management, and improved cost efficiency for patients and healthcare facilities alike.

Expansion into international markets, where telemedicine and digital health solutions are gaining traction, can provide DocGo Inc with access to a larger customer base and increased revenue streams. Localizing the platform to cater to specific languages and healthcare systems would be necessary for success in these markets.

Threats

The competitive landscape in the digital healthcare industry is intensifying, with both established players and new startups entering the market. DocGo Inc needs to differentiate its offerings and continuously innovate to stay ahead and maintain market share.

Data security and privacy concerns are critical in the healthcare sector. Any breach or unauthorized access to patient data could lead to severe reputational damage and legal consequences. DocGo Inc must invest in robust security measures to protect users' sensitive information.

Regulatory compliance is another potential threat for DocGo Inc. The company must stay updated with evolving healthcare regulations and ensure its platform adheres to data protection, user privacy, and medical compliance standards in all jurisdictions where it operates.

DocGo Segments

DocGo Revenue by Segment (1/2)

  • Max

Mobile Health Services
Transportation Services
Details
Date
Mobile Health Services
Transportation Services
Jan 1, 2023
442.79 M USD
181.50 M USD
Jan 1, 2024
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD

DocGo Revenue by Segment (2/2)

  • Max

Mobile Health Services
Transportation Services
Corporate
Details
Date
Mobile Health Services
Transportation Services
Corporate
Jan 1, 2023
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
423.13 M USD
193.43 M USD
0.00 USD
Jan 1, 2025
121.43 M USD
200.77 M USD
0.00 USD

DocGo Revenue by Region

  • Max

United States
U.K
United Kingdom
Details
Date
United States
U.K
United Kingdom
Jan 1, 2023
571.89 M USD
0.00 USD
52.40 M USD
Jan 1, 2024
558.79 M USD
57.76 M USD
0.00 USD
Jan 1, 2025
268.25 M USD
53.94 M USD
0.00 USD

DocGo Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

DocGo historical P/E ratio, EBIT multiple, and P/S ratio

DocGo annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

DocGo shares outstanding

The number of shares of DocGo was 109.42 M in 2025. This indicates how many shares DocGo is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
58.40 M Stocks
Jan 1, 2021
94.90 M Stocks
Jan 1, 2022
103.00 M Stocks
Jan 1, 2023
105.62 M Stocks
Jan 1, 2024
109.42 M Stocks
Jan 1, 2025 (e)
109.42 M Stocks
Jan 1, 2026 (e)
109.42 M Stocks
Jan 1, 2027 (e)
109.42 M Stocks

DocGo stock splits

In DocGo's history, there have been no stock splits.

Current DocGo forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
66.67 % (8)
Hold
33.33 % (4)
Sell
0.00 % (0)
12M Price Target
3.06
Last Price
0.63
Currency
USD
12M Return Potential
389.60 %
LTM Return
0 %

DocGo Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/10/2026-0.06USD-76.91 MUSD-2026 Q2
5/11/2026-0.10USD-73.87 MUSD-2026 Q1
3/16/2026-0.13USD-71.76 MUSD-2025 Q4
8/7/2025-0.10USD-79.12 MUSD-2025 Q2
5/6/20240.09USD-200.76 MUSD-2024 Q1
3/11/20240.11USD-198.10 MUSD-2023 Q4
11/6/20230.09USD-130.13 MUSD-2023 Q3
8/7/20230.08USD-123.90 MUSD-2023 Q2

EESG©

Eulerpool ESG Scorecard© for the DocGo stock

31/100
10
Environment
66
Social
16
Governance
E

Environment

20
Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees
Percentage of women in management
Percentage of Asian employees4
Share of Asian management11
Percentage of Hispanic/Latino employees19
Hispano/Latino Management share12
Percentage of Black employees31
Black Management Share10
Percentage of white employees40
White Management Share60
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

DocGo shareholder structure

% Name
5.99248%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
5.43514%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
5.05221%
Deerfield Management Company, L.P.
Deerfield Management Company, L.P.
3.27165%
P.A.W. Capital Partners, LP
P.A.W. Capital Partners, LP
3.13961%
Knott Partners Management, LLC
Knott Partners Management, LLC
2.94273%
S Squared Technology, LLC
S Squared Technology, LLC
...

DocGo Executives and Management Board

10 members · avg. age 61 · 10 % women

LB

Mr. Lee Bienstock (41)

Chief Executive Officer, Director · since 2022

7.56 M USD

Management

NR

Mr. Norman Rosenberg (55)

Chief Financial Officer, Treasurer

4.79 M USD
SS

Mr. Stephen Sugrue (53)

Chief Compliance Officer

1.84 M USD
EL

Mr. Eiwe Lingefors

Chief Information Officer

Board of Directors

ET

Mr. Ely Tendler (57)

General Counsel, Company Secretary, Director · since 2021

1.36 M USD
SK

Dr. Stephen Klasko (71)

Independent Chairman of the Board

575,000.00 USD
MB

Mr. Michael Burdiek (65)

Independent Director

150,000.00 USD
VL

Ms. Vina Leite (56)

Independent Director

150,000.00 USD
IS

Mr. Ira Smedra (76)

Independent Director

150,000.00 USD
JT

Mr. James Travers (73)

Independent Director

150,000.00 USD

Frequently asked questions about DocGo

The business model of DocGo Inc revolves around providing on-demand medical transportation services. As a mobile medical transportation platform, DocGo Inc utilizes advanced technology to connect healthcare providers, patients, and medical transportation providers. Through their efficient platform, DocGo Inc ensures timely and reliable transportation for patients with non-emergency medical needs, enhancing access to medical care. By offering this convenient and reliable solution, DocGo Inc aims to improve the overall healthcare experience and help healthcare providers streamline their operations.

DocGo Inc is primarily active in the healthcare industry.

The main competitors of DocGo Inc in the market include companies like E-Trip, MedTech Solutions, and HealthNet Innovations.

DocGo Inc is a leading company in the healthcare industry. Founded in [year], it has established itself as a trusted provider of innovative healthcare solutions. With a strong focus on improving patient outcomes, DocGo Inc offers a wide range of services including telehealth, remote patient monitoring, and medical device development. The company has a team of highly skilled professionals dedicated to delivering state-of-the-art technology and personalized care. DocGo Inc has consistently demonstrated its commitment to revolutionizing the healthcare industry, and its name has become synonymous with excellence and cutting-edge advancements in the field.

Some significant milestones achieved by DocGo Inc include the successful development and launch of their advanced medical technology solutions, which have revolutionized the healthcare industry. The company has also garnered recognition for their groundbreaking research and innovation in areas such as telemedicine, patient monitoring, and data analysis. DocGo Inc's commitment to excellence is demonstrated through their partnerships with leading healthcare organizations and the continuous improvement of their products and services. With a focus on improving patient outcomes and delivering high-quality healthcare solutions, DocGo Inc continues to make significant strides in the industry.

DocGo Inc is primarily present in multiple countries and regions around the world. Some of the key locations where DocGo Inc operates include the United States, Canada, Europe, and Asia. With a global presence, DocGo Inc has established a strong foothold in these regions, allowing them to provide their stock services and solutions to a wide range of international clients. Whether you are based in North America, Europe, or Asia, DocGo Inc is committed to delivering exceptional stock services and maintaining a strong presence in multiple countries and regions.

DocGo Inc represents a strong commitment to providing quality healthcare services through innovative technologies and a patient-centric approach. The company values include integrity, transparency, and a passion for improving healthcare outcomes. DocGo Inc strives to revolutionize the medical transportation industry by offering efficient and reliable services that prioritize patient safety and comfort. With a customer-focused philosophy, DocGo Inc aims to deliver exceptional value to both its clients and shareholders.

Analysts currently set an average price target of 2.55 USD for the DocGo stock (median: 3.06 USD), implying +308.0 % versus the latest price. The consensus is based on 12 analyst ratings.

12 analysts currently rate the DocGo stock: 8 recommend buying, 4 holding and 0 selling. For 2026, analysts expect DocGo to generate revenue of 297.18 M USD and earnings per share of -0.31 USD.

Converted at the current exchange rate, the DocGo share trades at 0.54 EUR (0.63 USD).

The DocGo share (DCGO) is listed on 1 stock exchanges, including: NASDAQ (DCGO).

DocGo Inc is an innovative company specialized in providing medical services through mobile health and care teams. Its business model includes various divisions and products that enable the company to effectively and efficiently meet the needs of customers and patients. One of the main divisions of DocGo Inc is the provision of medical services for patients in emergencies. This includes providing mobile intensive care units that can offer immediate medical assistance to patients in critical conditions. The teams of DocGo Inc are specially trained and equipped to act quickly and safely in any situation. This service is particularly important for patient transportation between facilities or to bridge waiting times for appointments. Another important division of DocGo Inc is telemedicine. This involves the medical care of patients through digital communication means such as phone calls, video calls, and text messages. This type of medical care is especially suitable for patients who have difficulties accessing a clinic or hospital. Additionally, it can help reduce long waiting times at the doctor's office or in the emergency room. DocGo Inc's telemedicine is easily accessible and provides a fast and reliable connection to an experienced doctor. Another product offered by DocGo Inc is mobile diagnostics. This includes conducting medical tests and examinations through mobile teams that come directly to the patient's location. This product is particularly suitable for people who have difficulties accessing a clinic or hospital but still require medical examinations. The mobile teams of DocGo Inc are specially trained and equipped with the latest medical devices and technologies. Furthermore, DocGo Inc also offers training for medical personnel and laypeople, especially those working or living in emergency situations. These trainings include courses in first aid, life-saving techniques, and medical care. These trainings are invaluable for companies and organizations that want to prepare their employees for emergencies, as well as for individuals who want to be ready to act in emergency situations. Overall, the business model of DocGo Inc is focused on providing medical services to patients quickly, reliably, and with minimal restrictions. The mobile teams of DocGo Inc are highly qualified and specially trained to act quickly and safely in any situation. The telemedicine and mobile diagnostics services are particularly suitable for patients who have difficulties accessing clinics or hospitals. Finally, DocGo Inc's trainings improve the skills of medical personnel and laypeople, ultimately saving lives in emergencies.

The expected revenue of DocGo is 297.18 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of DocGo is -34.32 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of DocGo is currently -1.99. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the DocGo stock.

The price-to-sales ratio (P/S) of DocGo is currently 0.23. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the DocGo stock.

The Eulerpool Quality Score for DocGo is 3/10.

The ISIN of DocGo is US2560861096. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of DocGo is DCGO. The ticker symbol is used to trade DocGo shares on the stock exchange.

DocGo paid dividends every year for the past 0 years.

DocGo is assigned to the 'Health' sector.

The dividends of DocGo are distributed in USD.

All fundamentals and in-depth analysis of DocGo

Our stock analysis for DocGo stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DocGo. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.